Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Vaccinex, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- 0 vs. Q1 2023
- Shares held
- 2.82M
- +70.6K (+2.6%) vs. Q1 2023
- Total value
- $994.8K
- −$104.6K (−9.5%) vs. Q1 2023
- New holders
- 4
- 5 more added
- Sold out
- 4
- 4 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VCNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $45 |
| Q3 2024 | 12 | $1.14M |
| Q2 2024 | 11 | $1.81M |
| Q1 2024 | 12 | $2.41M |
| Q4 2023 | 18 | $1.07M |
| Q3 2023 | 19 | $2.92M |
| Q2 2023 | 23 | $994.8K |
| Q1 2023 | 24 | $1.10M |
| Q4 2022 | 25 | $3.12M |
| Q3 2022 | 22 | $2.28M |
| Q2 2022 | 27 | $5.03M |
| Q1 2022 | 25 | $5.49M |
| Q4 2021 | 21 | $1.68M |
| Q3 2021 | 23 | $3.36M |
| Q2 2021 | 28 | $4.54M |
| Q1 2021 | 33 | $2.79M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Vaccinex, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 1,352,570 | $472.2K | 0.19% | +400,769+42.1% | Added |
| Vanguard Group Inc | 732,859 | $260.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 250,186 | $89.1K | 0.00% | 00.0% | Unchanged |
| Worth Venture Partners, LLC | 138,795 | $49.4K | 0.03% | 00.0% | Unchanged |
| Citadel Advisors LLC | 103,084 | $36.7K | 0.00% | +68,551+198.5% | Added |
| State Street Corp | 71,400 | $25.4K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 46,276 | $16.0K | 0.00% | +46,276 | New |
| Tower Research Capital LLC (TRC) | 31,415 | $11.2K | 0.00% | +7,141+29.4% | Added |
| Northern Trust Corp | 23,369 | $8.32K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 17,225 | $6.13K | 0.00% | −1,446−7.7% | Reduced |
| Vectors Research Management, LLC | 10,000 | $4.00K | 0.00% | +10,000 | New |
| Creative Planning | 11,000 | $3.92K | 0.00% | 00.0% | Unchanged |
| Moors & Cabot, Inc. | 10,000 | $3.56K | 0.00% | 00.0% | Unchanged |
| Courier Capital LLC | 10,000 | $3.56K | 0.00% | +10,000 | New |
| Advisor Group Holdings, Inc. | 3,500 | $1.25K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 4,657 | $1.00K | 0.00% | +534+13.0% | Added |
| Financial Connections Group, Inc. | 4,044 | $1.00K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 2,566 | $913 | 0.00% | −49,631−95.1% | Reduced |
| Morgan Stanley | 300 | $107 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 251 | $89 | 0.00% | +59+30.7% | Added |
| Cornerstone Planning Group LLC | 200 | $71 | 0.00% | +200 | New |
| UBS Group AG | 100 | $36 | 0.00% | −16,235−99.4% | Reduced |
| Simplex Trading, LLC | 340 | $0 | 0.00% | −59,219−99.4% | Reduced |
| Millennium Management LLC | 0 | $0 | 0.00% | −111,098−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −103,898−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −99,105−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −32,305−100.0% | Sold out |
| HNP Capital LLC | – | – | – | – | Not filed |